All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 37 of 206 pages ‹ First  < 35 36 37 38 39 >  Last ›

HSL15469
Edwards D, Ballantyne A.
Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors
Internal Medicine Journal 2009 Apr 8;39:(3):191 - 196
http://www3.interscience.wiley.com/journal/122313368/abstract?CRETRY=1&SRETRY=0

HSL15962
Shaywitz DA, Stossel TP.
It's Time to Fight the 'PharmaScolds'
The Wall Street Journal 2009 Apr 8
http://online.wsj.com/article/SB123914780537299005.html

HSL15414
Silverman E.
Psyched Out: Brown's Marty Keller to Step Down
The Invivo Blog 2009 Apr 7
http://invivoblog.blogspot.com/2009/04/psyched-out-browns-marty-keller-to-step.html

HSL15420
Lewis S, Dunlevy S.
Prescriptions to cost less thanks to Federal Budget plan
The Advertiser 2009 Apr 7
http://www.news.com.au/adelaidenow/story/0,22606,25306710-5006301,00.html

HSL15533
New Report Urges FDA Clinical Trial Reform
Government Accountability Project 2009 Apr 7
http://web.archive.org/web/20091227130450/http://www.whistleblower.org/content/press_detail.cfm?press_id=1613

HSL15407
Gaouette N.
Grassley Probes Financing of Advocacy Group for Mental Health
Bloomberg.com 2009 Apr 6
http://www.bloomberg.com/apps/news?pid=20601124&sid=a4V6UEpXf_mY

HSL15409
FDA Sends Letters to 14 Companies Regarding Internet Ads
Pharma Live 2009 Apr 6
http://pharmalive.com/news/index.cfm?articleID=616907

HSL15410
Moynihan R.
Court hears how drug giant Merck tried to 'neutralise' and 'discredit' doctors critical of Vioxx
BMJ 2009 Apr 6;338:
http://www.bmj.com/cgi/content/extract/338/apr06_1/b1432

HSL15411
Berkrot B, Pierson R.
Ex Bristol - Myers Exec Pleads Guilty In Plavix Case
The New York Times 2009 Apr 6
http://www.nytimes.com/reuters/2009/04/06/business/business-us-bristolmyers-executive.html?_r=1&pagewanted=print

HSL15413
Miley M.
FDA Demands Pharma Stops 'Misleading' Ads on Google, Yahoo
The Advertising Age 2009 Apr 6
http://adage.com/article?article_id=135818

HSL15415
Foreman J.
Drug ad alert
Boston.com 2009 Apr 6
http://www.boston.com/news/health/articles/2009/04/06/drug_ad_alert/?s_campaign=8315

HSL15418
Angell M.
Charting a new course at the FDA
Boston.com 2009 Apr 6
http://www.boston.com/bostonglobe/editorial_opinion/oped/articles/2009/04/06/charting_a_new_course_at_the_fda/

HSL15474
Goozner M.
Who Will Pay for CME If Industry Doesn't?
Gooznews.com 2009 Apr 6
http://www.medcitynews.com/2009/04/who-will-pay-for-cme-if-industry-doesnt/

HSL15476
Howden D.
Pfizer to pay £50m after deaths of Nigerian children in drug trial experiment
The Independent 2009 Apr 6
http://www.independent.co.uk/news/world/africa/pfizer-to-pay-16350m-after-deaths-of-nigerian-children-in-drug-trial-experiment-1663402.html

HSL15390
Hundley K.
To move more prescription drugs, sales reps sling swag
St Petersburg Times 2009 Apr 5
http://www.tampabay.com/news/health/article989451.ece

HSL15391
Hill M.
Conflicts for FDA committee set to weigh risks of Seroquel
The Philadelphia Inquirer 2009 Apr 4
http://www.philly.com/inquirer/business/20090404_Conflicts_for_FDA_committee_set_to_weigh_risks_of_Seroquel.html

HSL15398
Stephens J.
Pfizer Reaches Settlement In Nigerian Drug-Trial Case
The Washington Post 2009 Apr 4
http://www.washingtonpost.com/wp-dyn/content/article/2009/04/03/AR2009040301877.html

HSL15403
Favole JA.
US cracks down on misleading drug internet advertising
The Australian 2009 Apr 4
http://www.theaustralian.news.com.au/story/0,24897,25287882-7582,00.html

HSL15419
Mack J.
FDA's Actions Speak Louder than Its Words: On the Internet It's the Medium as Well as the Message!
Pharma Marketing Blog 2009 Apr 4
http://pharmamkting.blogspot.com/2009/04/fdas-actions-speak-louder-than-its.html

HSL15372
Guild TGA petition
Pharmacy Daily (Australia) - registration required 2009 Apr 3
http://www.pharmacydaily.com.au

HSL15399
Drug company ad raises ire of Health Commissioner
Radio New Zealand News 2009 Apr 3
http://www.radionz.co.nz/news/stories/2009/04/03/1245a957dc65

HSL15408
Hurn ME, Todé C.
Pharma dollars shifting to digital
DM News 2009 Apr 3
http://www.dmnews.com/Pharma-dollars-shifting-to-digital/article/130117/

HSL15434
Timonen J, Karttunen P, Bengtström M, Ahonen R.
The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland.
Health Policy 2009 Apr 3;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8X-4W0R3B1-5&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=818c9e5bd18f9c2613a6ce2e2821ac9e

HSL15492
Sweeney JF.
Pharma 'rebels' growing in number
Modern Medicine 2009 Apr 3
http://www.modernmedicine.com/modernmedicine/Medical+Economics/Pharma-rebels-growing-in-number/ArticleStandard/Article/detail/588457?contextCategoryId=40145

HSL15387
Goldberg C.
Firms tied to some MDs who set policy
Boston.com 2009 Apr 2
http://www.boston.com/news/local/massachusetts/articles/2009/04/02/firms_tied_to_some_mds_who_set_policy/

HSL15388
Rubenstein S.
Authors of Psychiatric Guidelines Get Funding from Drug Makers
The Wall Street Journal Blog 2009 Apr 2
http://blogs.wsj.com/health/2009/04/02/authors-of-psychiatric-guidelines-get-funding-from-drug-makers/

HSL15400
AHCJ
AHCJ releases letter to the editor of JAMA
: AHCJ 2009 Apr 2
http://www.healthjournalism.org/about-news-detail.php?id=68

HSL15451
Blackwell T.
Study on cholesterol drugs raises ethical questions
Ottawa Citizen 2009 Apr 2
http://web.archive.org/web/20090417075829/http://www.ottawacitizen.com/Health/Study+cholesterol+drugs+raises+ethical+questions/1457939/story.html

HSL15370
Taylor L.
US courts 'failing' on pay-for-delay generic deals
Pharma Times 2009 Apr 1
http://www.pharmatimes.com/WorldNews/article.aspx?id=15602

HSL15377
Rout M.
Vioxx maker Merck and Co drew up doctor hit list
The Australian 2009 Apr 1
http://www.theaustralian.news.com.au/story/0,25197,25272600-2702,00.html

HSL15378
Rothman DJ, McDonald WJ, Berkowitz CD, Chimonas SC, Deangelis CD, Hale RW, Nissen SE, Osborn JE, Scully JH, Thomson GE, Wofsy D.
Professional Medical Associations and Their Relationships With Industry
JAMA 2009 Apr 1;301:(13):1367-1372
http://jama.ama-assn.org/cgi/content/abstract/301/13/1367?etoc

HSL15379
Grogan K.
PMAs urged to cut funding from pharma down to 0%
Pharma Times 2009 Apr 1
http://www.pharmatimes.com/WorldNews/article.aspx?id=15604

HSL15386
Rockoff JD.
Stanford Medical School to Disclose More About Industry Comp
The Wall Street Journal Blog 2009 Apr 1
http://blogs.wsj.com/health/2009/04/01/stanford-medical-school-to-disclose-more-about-industry-comp/

HSL15389
Cox L.
Top 7 Celebrity Drug Endorsements: Commercial or a Cause?
ABC News 2009 Apr 1
http://abcnews.go.com/Health/CelebrityCafe/story?id=7209401

HSL15401
Goozner M.
Will Professional Medical Associations End Industry Ties?
Gooznews.com 2009 Apr 1
http://www.scribd.com/doc/57391910/JAMA-Relationships-With-Industry

HSL15404
Edwards J.
Boehringer Ingelheim and 8 Other Companies Caught Selling Illegal Painkillers
BNET 2009 Apr 1
http://industry.bnet.com/pharma/10001558/boehringer-ingelheim-and-8-other-companies-caught-selling-illegal-painkillers/

HSL15406
Naik AD, Woofter AL, Skinner JM, Abraham NS.
Pharmaceutical company influence on nonsteroidal anti-inflammatory drug prescribing behaviors.
Am J Manag Care 2009 Apr 1;15:(4):e9-e15
http://www.ajmc.com/pubMed.php?pii=11097

HSL15438
Rabin RC.
Doctors Urge End to Corporate Ties
The New York Times 2009 Apr 1
http://www.nytimes.com/2009/04/02/health/policy/02journal.html?_r=1

HSL15443
Scull A.
The madness of Big Pharma
The Times Literary Supplement 2009 Apr 1
http://entertainment.timesonline.co.uk/tol/arts_and_entertainment/the_tls/article6013955.ece

HSL15613
Arnold M, Comer B.
DDMAC, pharmas mull Web 2.0 rules
Medical Marketing & Media 2009 Apr 1
http://www.highbeam.com/doc/1G1-198169518.html

HSL15614
Chase, J
Alcon Labs uses brains to test ad effectiveness
Medical Marketing & Media 2009 Apr 144:(4):28
http://www.mmm-online.com/Alcon-Labs-uses-brains-to-test-ad-effectiveness/article/129850/

HSL15371
Alam K, Shah AK, Ojha P, Palaian S, Shankar PR.
Evaluation of drug promotional materials in a hospital setting in Nepal
Southern Med Review 2009 Apr;2:(1):2-6
http://www.fmhs.auckland.ac.nz/sop/smr/_docs/SMR_Vol2_Issue1.pdf

HSL15461
PhRMA
Principles on Conduct of Clinical Trials: Communication of Clinical Trial Results
: PhRMA 2009 Apr
http://books.google.com.au/books?id=WijY8_miohQC&pg=PA132&lpg=PA132&dq=The+Pharmaceutical+Research+and+Manufacturers+of%0AAmerica+(PhRMA)+represents+research-based+pharmaceutical%0Aand+biotechnology+companies.+Our%0Amembers+discover,+develop,+manufacture+and+market+new%0Amedicines+and+vaccines+to+enable+patients+to+live+longer+and%0Ahealthier+lives.%0AThe+development+of+new+therapies+to+treat+disease+and%0Aimprove+quality+of+life+is+a+long+and+complex+process.+A+critical%0Apart+of+that+process+is+clinical+research,+the+study+of+a%0Apharmaceutical+product+in+humans+(research+participants).%0AClinical+research+involves+both+potential+benefits+and+risks+to%0Athe+participants+and+to+society+at+large.+Investigational+clinical%0Aresearch+is+conducted+to+answer+specific+questions,+and+some%0Aaspects+of+the+therapeutic+profile+(benefits+and+risks)+of+the%0Aproduct(s)+tested+cannot+be+fully+known+without+study+in%0Ahumans.+In+sponsoring+and+conducting+clinical+research,%0APhRMA+members+place+great+importance+on+respecting+and%0Aprotecting+the+safety+of+research+participants.%0APrinciples+for+the+conduct+of+clinical+research+are+set+forth+in%0Ainternationally+recognized+documents,+such+as+the+Declaration%0Aof+Helsinki+and+the+Guideline+for+Good+Clinical+Practice+of+the%0AInternational+Conference+on+Harmonization+(ICH).&source=bl&ots=_3NZSoatkl&sig=eV8SaUlyJOvHwDVWJVMGpHgss5w&hl=en&sa=X&ei=2KQTT42DIqaUiQe7r8DdCw&ved=0CCEQ6AEwAA#v=onepage&q=The%20Pharmaceutical%20Research%20and%20Manufacturers%20of%20America%20(PhRMA)%20represents%20research-based%20pharmaceutical%20and%20biotechnology%20companies.%20Our%20members%20discover%2C%20develop%2C%20manufacture%20and%20market%20new%20medicines%20and%20vaccines%20to%20enable%20patients%20to%20live%20longer%20and%20healthier%20lives.%20The%20development%20of%20new%20therapies%20to%20treat%20disease%20and%20improve%20quality%20of%20life%20is%20a%20long%20and%20complex%20process.%20A%20critical%20part%20of%20that%20process%20is%20clinical%20research%2C%20the%20study%20of%20a%20pharmaceutical%20product%20in%20humans%20(research%20participants).%20Clinical%20research%20involves%20both%20potential%20benefits%20and%20risks%20to%20the%20participants%20and%20to%20society%20at%20large.%20Investigational%20clinical%20research%20is%20conducted%20to%20answer%20specific%20questions%2C%20and%20some%20aspects%20of%20the%20therapeutic%20profile%20(benefits%20and%20risks)%20of%20the%20product(s)%20tested%20cannot%20be%20fully%20known%20without%20study%20in%20humans.%20In%20sponsoring%20and%20conducting%20clinical%20research%2C%20PhRMA%20members%20place%20great%20importance%20on%20respecting%20and%20protecting%20the%20safety%20of%20research%20participants.%20Principles%20for%20the%20conduct%20of%20clinical%20research%20are%20set%20forth%20in%20internationally%20recognized%20documents%2C%20such%20as%20the%20Declaration%20of%20Helsinki%20and%20the%20Guideline%20for%20Good%20Clinical%20Practice%20of%20the%20International%20Conference%20on%20Harmonization%20(ICH).&f=false

HSL15495
Impey D.
The blame game
PM Live 2009 Apr
http://www.pmlive.com/find_an_article/allarticles/categories/General/2009/april/features/the_blame_game

HSL15500
Lexchin J
Drug Safety and Health Canada: Going, Going…Gone?
: Canadian Centre for Policy Alternatives 2009 Apr
http://www.policyalternatives.ca/~ASSETS/DOCUMENT/National_Office_Pubs/2009/Drug_Safety_and_Health_Canada.pdf

HSL15526
Hirotsu M, Sohma M, Takagi H.
[Involvement of medical representatives in team medical care].
Gan To Kagaku Ryoho 2009 Apr;36:(4):693-5
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=36040&seq=35

HSL15527
Hinsch K.
Bad Doc, Greedy Doc?
womensbioethicsproject 2009 Apr
http://www.womensbioethics.org/index.php?p=Do_You_Tip_Your_Docs_for_Botox&s=335

HSL15551
Institute of Medicine
Conflict of Interest in Medical Research, Education, and Practice: A Focus on Medical Research
: Institute of Medicine 2009 Apr
http://www.iom.edu/~/media/Files/Report%20Files/2009/Conflict-of-Interest-in-Medical-Research-Education-and-Practice/COI%20research%20report%20brief%20for%20web.pdf

HSL15605
Alkhateeb FM, Khanfar NM, Doucette WR, Loudon D.
Characteristics of Physicians Targeted by the Pharmaceutical Industry to Participate in E-detailing.
Health Mark Q. 2009 Apr;26:(2):98-116
http://www.ncbi.nlm.nih.gov/pubmed/19408179

HSL15999
Rimonabant: marketing authorization suspended... at last: withdrawal. Half-measures.
Prescrire Int 2009 Apr;18:(100):16
http://www.ncbi.nlm.nih.gov/pubmed/19585720

HSL16083
Martinez LS, Lewis N.
The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth.
J Health Commun. 2009 Apr-May;14:(3):246-61
http://www.informaworld.com/smpp/content~db=all?content=10.1080/10810730902805820

HSL16084
Moliner J, Mozota J, María Abad J, Casaña L, Júdez D, José Rabanaque M
[Is it appropriate to research into physician-pharmaceutical industry relationships?]
Rev Calid Asist 2009 Apr;24:(2):72-9
http://www.ncbi.nlm.nih.gov/pubmed/19426930

HSL16386
Kraepelin E, Freud S, Healy D.
Kraepelin-fraud syndrome.
Med Hypotheses 2009 Apr;72:(4):378-80 Epub
http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(08)00662-2

HSL16664
Sismondo S.
Ghosts in the machine: publication planning in the medical sciences.
Soc Stud Sci 2009 Apr;39:(2):171-98
http://www.ncbi.nlm.nih.gov/pubmed/19831220

HSL15362
Vioxx danger claim
Herald Sun 2009 Mar 31
http://www.news.com.au/heraldsun/story/0,21985,25266185-2862,00.html

HSL15374
Luchter L.
Prilosec OTC Firing Up BBQ At NASCAR
Marketing Daily 2009 Mar 31
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=103202

HSL15381
Cialis, Cymbalta Lead 2008’s Most Recalled Drug Ads
Pharma Live 2009 Mar 31
http://pharmalive.com/news/index.cfm?articleID=615946

HSL15384
Garattini S, Chalmers I.
Patients and the public deserve big changes in evaluation of drugs.
BMJ 2009 Mar 31;338:b1025:
http://www.bmj.com/cgi/content/extract/338/mar31_3/b1025

HSL15385
Tremblay M.
Commentary: Risks of doing as the Romans do.
BMJ 2009 Mar 31;338:b1107:
http://www.bmj.com/cgi/content/extract/338/mar31_3/b1107

HSL15392
Herper M.
A Doctor, Not A Nascar Driver
Forbes.com 2009 Mar 31
http://www.forbes.com/2009/03/31/acc-conference-pharmacuticals-advertising-business-healthcare-drug-ads.html

HSL15393
Tanne JH.
JAMA's new rule on whistleblowers creates controversy.
BMJ 2009 Mar 31;338:b1352:
http://www.bmj.com/cgi/content/extract/338/mar31_2/b1352

HSL15351
Pharma events vital
Pharmacy Daily (Australia) - registration required 2009 Mar 30
http://www.pharmacydaily.com.au

HSL15360
Rout M.
Class action against drug begins today
The Australian 2009 Mar 30
http://www.theaustralian.news.com.au/story/0,25197,25260867-23289,00.html

HSL15361
Hagan K.
Firm denies drug cover-up
The Advertising Age 2009 Mar 30
http://www.theage.com.au/national/firm-denies-drug-coverup-20090329-9fkp.html

HSL15363
Mansell P.
IRB system flaws exposed at US Congressional hearing
Pharma Times 2009 Mar 30
http://www.pharmatimes.com/clinicalnews/article.aspx?id=15584

HSL15364
Federal Disclosure Would Help Editors Find Cheats
Integrity In Science 2009 Mar 30
http://www.cspinet.org/integrity/watch/index.html#1

HSL15367
Goldstein J.
AMA Wades Into Flap Over JAMA Editors
The Wall Street Journal Blog 2009 Mar 30
http://blogs.wsj.com/health/2009/03/30/ama-wades-into-flap-over-jama-editors/

HSL15380
Convey E.
Drug sales exec pleads guilty in Bextra case
Boston Business Journal 2009 Mar 30
http://boston.bizjournals.com/boston/stories/2009/03/30/daily25.html

HSL15337
Hundley K.
Approval process lowers the number of kids on atypical prescriptions.
St Petersburg Times 2009 Mar 29
http://www.tampabay.com/news/health/article987612.ece

HSL15365
Rust S, Fauber J.
Drug firms' cash skews doctor classes
JSOnline 2009 Mar 29
http://www.jsonline.com/news/42064977.html

HSL15369
Armstrong D.
Medical Group Seeks Probe of Its Journal
The Wall Street Journal 2009 Mar 28
http://online.wsj.com/article/SB123819137827260883.html

HSL15397
Cresswell A.
Drug companies censured over lavish doctors' seminars
The Australian 2009 Mar 28
http://www.theaustralian.news.com.au/story/0,25197,25253284-23289,00.html

HSL15336
Mashta O.
Banning drugs from NHS stifles new development, drug company says.
BMJ 2009 Mar 27;338:b1295:
http://www.bmj.com/cgi/content/extract/338/mar27_2/b1295?papetoc

HSL15338
IMS, SDI Seek U.S. Supreme Court Review in Critical First Amendment Case
Pharma Live 2009 Mar 27
http://pharmalive.com/news/index.cfm?articleID=614990

HSL15339
Vedantam S.
Debate Over Drugs For ADHD Reignites
The Washington Post 2009 Mar 27
http://www.washingtonpost.com/wp-dyn/content/article/2009/03/26/AR2009032604018_pf.html

HSL15341
Luchter L.
Firm Faulted With Targeting Pharma Ads At Survey Respondents
Marketing Daily 2009 Mar 27
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=102947

HSL15342
Nonprofit Hits JAMA Editors, Urges Inquiry
The Wall Street Journal 2009 Mar 27
http://online.wsj.com/article/SB123810131860651487.html

HSL15359
Diller L.
Powerful proponent of psychiatric drugs for children primed for a fall
The San Francisco Chronicle 2009 Mar 27
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2009/03/27/EDAF16N963.DTL

HSL15366
Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
Pharma Live 2009 Mar 27
http://pharmalive.com/news/index.cfm?articleID=615034

HSL15373
Woodhead M.
More drug company dinners
6minutes (Australia) 2009 Mar 27
http://www.6minutes.com.au/dirplus/images/6minutes/newspluspharma/27_03_2009.pdf

HSL15383
Nathan VL.
UPDATE 1-Par Pharma gets subpoena on unit's promotional practice
Reuters 2009 Mar 27
http://www.reuters.com/article/rbssHealthcareNews/idUSBNG39708120090327

HSL15394
Gever J.
Little Policing to Guard Against Tainted Ivory Towers
MedPageToday 2009 Mar 27
http://www.medpagetoday.com/PublicHealthPolicy/Ethics/13454

HSL15395
Neale T.
GAO Sting Shows Independent Review Boards Are Vulnerable to Fraud
MedPage Today 2009 Mar 27
http://www.medpagetoday.com/PublicHealthPolicy/ClinicalTrials/13471

HSL15475
Reveler N.
Abolish DTCA ban, suggests CRTC boss
Media In Canada 2009 Mar 27
http://www.mediaincanada.com/articles/mic/20090327/crtc.html?__s=yes

HSL15333
Repeat form ads banned
Pharmacy Daily (Australia) - registration required 2009 Mar 26
http://www.pharmacydaily.com.au

HSL15335
Harris G.
Bill Would Let Copycats Compete With Biotech Drugs
The New York Times 2009 Mar 26
http://www.nytimes.com/2009/03/27/health/policy/27drug.html?ref=3Dus

HSL15348
Schachter SC, Mandell W, Harshbarger S, Grometstein R.
Managing Relationships with Industry: A Physician's Compliance Manual
The New England Journal of Medicine 2009 Mar 26;360:(13):1366-1367
http://content.nejm.org/cgi/content/short/360/13/1366

HSL15368
CVS Caremark's Objectionable Drug Marketing Practices Raised at Massachusetts Joint Committee on Health Care Financing Hearing Today, According to CtW
Pharma Live 2009 Mar 26
http://pharmalive.com/news/index.cfm?articleID=614723

HSL15334
Clifford S.
Online Age Quiz Is a Window for Drug Makers
The New York Times 2009 Mar 25
http://www.nytimes.com/2009/03/26/technology/internet/26privacy.html?_r=4&hp

HSL15340
Mansell P.
GSK steps up commitment to research transparency
Pharma Times 2009 Mar 25
http://www.pharmatimes.com/clinicalnews/article.aspx?id=15559

HSL15344
The American Psychiatric Association Phases Out Industry-Supported Symposia
Pharma Live 2009 Mar 25
http://pharmalive.com/news/index.cfm?articleID=614455

HSL15345
Wang SS.
Psychiatrists to Stop Taking Meeting Money From Drug Makers
The Wall Street Journal Blog 2009 Mar 25
http://blogs.wsj.com/health/2009/03/25/psychiatrists-to-stop-taking-meeting-money-from-drug-makers/

HSL15346
Tanne JH.
US justice department sues company for off-label promotion of antidepressants for children.
BMJ 2009 Mar 25;338:b1222:
http://www.bmj.com/cgi/content/extract/338/mar25_3/b1222?papetoc

HSL15347
Shaughnessy AF.
An insider’s view of the drug industry
BMJ 2009 Mar 25;338:
http://www.bmj.com/cgi/content/extract/338/mar25_1/b1138?papetoc

HSL15353
Grogan K.
GSK puts 800 patents in 'pool', expands trials transparency
Pharma Times 2009 Mar 25
http://www.pharmatimes.com/WorldNews/article.aspx?id=15555&src=EWorldNews

HSL15396
Carey B.
Psychiatric Group Ends Industry-Sponsored Seminars
The New York Times 2009 Mar 25
http://www.nytimes.com/2009/03/26/health/26psych.html?_r=1

HSL15321
CH reform vital - Harvey
Pharmacy Daily (Australia) - registration required 2009 Mar 24
http://www.pharmacydaily.com.au

HSL15349
Boseley S.
Drug giants urged to create patent pools
The Guardian 2009 Mar 24
http://www.guardian.co.uk/society/2009/mar/24/pharamcuticals-patent-pools-hiv-drugs

HSL15352
Jack A.
GSK promises full drug trial disclosure
The Financial Times.com 2009 Mar 24
http://www.ft.com/cms/s/0/0976f2f2-18a7-11de-bec8-0000779fd2ac.html?nclick_check=1

HSL15354
Grogan K.
Merck & Co “targeted” by US government over Vioxx
Pharma Times 2009 Mar 24
http://www.pharmatimes.com/worldnews/article.aspx?id=15552

Page 37 of 206 pages ‹ First  < 35 36 37 38 39 >  Last ›